Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase NA 14Phase 3 13Phase 1 4Phase 4 3Phase 2/3 2Phase 1/2 2

Status

Completed 6Recruiting 5Terminated 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 364Other hematologic neoplasm 363Gastrointestinal 349Thoracic 329Other solid neoplasm 233Genitourinary 202Breast 197Dermatologic 188CNS 179Gynecologic 149Tumor-Agnostic 144Plasma cell 140Head & Neck 137Sarcoma 113Myeloid 97Endocrine 21Classical hematology 15NET 10Other neoplasm 5Other 4

Conditions

Mucositis 3Stomatitis 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Head and Neck Neoplasms 1Chemotherapy-induced Peripheral Neuropathy 1Carcinoma, Squamous Cell 1

Interventions

angiotensin I (1-7) 1ART123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Other × Clear all
NCT05251727 2024-08-19

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Veloxis Pharmaceuticals

Phase 1 Terminated
77 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT01092975 2020-12-28

Safety of Phenylephrine for Oral Mucositis Prevention

University of Wisconsin, Madison

Phase 1 Terminated
1 enrolled
Other

Stomatitis, Mucositis

NCT01300611 2020-12-08

USBTXA127CBT

Tarix Pharmaceuticals

Phase 1 Terminated
20 enrolled
LymphoidMyeloidOtherOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Mucositis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00427102 2012-11-14

MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Terminated
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡